Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. (Q53247401)
Jump to navigation
Jump to search
scientific article published on 31 October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. |
scientific article published on 31 October 2006 |
Statements
Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. (English)
Céline Bossard
Karim Belhadj
Felix Reyes
Nadine Martin-Garcia
Françoise Berger
Jean Alain Kummer
Josette Brière
Anne-Catherine Baglin
Stéphane Cheze
Jacques Bosq
Vincent Ribrag
Christian Gisselbrecht
Nicolas Mounier
Philippe Gaulard
31 October 2006
109
5
2183-2189